The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity

Objectives: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic cha...

Full description

Saved in:
Bibliographic Details
Published inInternational Journal of Obesity Vol. 39; no. 8; pp. 1241 - 1248
Main Authors Chen, H-H, Tseng, Y J, Wang, S-Y, Tsai, Y-S, Chang, C-S, Kuo, T-C, Yao, W-J, Shieh, C-C, Wu, C-H, Kuo, P-H
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.08.2015
Nature Publishing Group
Subjects
Online AccessGet full text
ISSN0307-0565
1476-5497
1476-5497
DOI10.1038/ijo.2015.65

Cover

Loading…
Abstract Objectives: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity. Methods: We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography–mass spectrometry and gas chromatography–mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways. Results: A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation. Conclusion: Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes.
AbstractList Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity. We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways. A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation. Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes.
International Journal of Obesity (2015) 39, 1241-1248; doi:10.1038/ijo.2015.65
Objectives:Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity.Methods:We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography–mass spectrometry and gas chromatography–mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways.Results:A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation.Conclusion:Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes.
OBJECTIVES: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity. METHODS: We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways. RESULTS: A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation. CONCLUSION: Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes. International Journal of Obesity (2015) 39, 1241-1248; doi:10.1038/ijo.2015.65
Objectives: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity. Methods: We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography–mass spectrometry and gas chromatography–mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways. Results: A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation. Conclusion: Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes.
Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity.OBJECTIVESMechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both healthy and subjects with abnormal obesity to identify potential metabolic pathways that may regulate the different metabolic characteristics of obesity.We recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways.METHODSWe recruited subjects with body mass index (BMI) over 25 from the weight-loss clinic of a central hospital in Taiwan. Metabolic healthy obesity (MHO) is defined as without having any form of hyperglycemia, hypertension and dyslipidemia, while metabolic abnormal obesity (MAO) is defined as having one or more abnormal metabolic indexes. Serum-based metabolomic profiling using both liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry of 34 MHO and MAO individuals with matching age, sex and BMI was performed. Conditional logistic regression and partial least squares discriminant analysis were applied to identify significant metabolites between the two groups. Pathway enrichment and topology analyses were conducted to evaluate the regulated pathways.A differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation.RESULTSA differential metabolite panel was identified to be significantly differed in MHO and MAO groups, including L-kynurenine, glycerophosphocholine (GPC), glycerol 1-phosphate, glycolic acid, tagatose, methyl palmitate and uric acid. Moreover, several metabolic pathways were relevant in distinguishing MHO from MAO groups, including fatty acid biosynthesis, phenylalanine metabolism, propanoate metabolism, and valine, leucine and isoleucine degradation.Different metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes.CONCLUSIONDifferent metabolomic profiles and metabolic pathways are important for distinguishing between MHO and MAO groups. We have identified and discussed the key metabolites and pathways that may prove important in the regulation of metabolic traits among the obese, which could provide useful clues to study the underlying mechanisms of the development of abnormal metabolic phenotypes.
Audience Academic
Author Chang, C-S
Yao, W-J
Tsai, Y-S
Kuo, P-H
Kuo, T-C
Chen, H-H
Wang, S-Y
Tseng, Y J
Wu, C-H
Shieh, C-C
Author_xml – sequence: 1
  givenname: H-H
  surname: Chen
  fullname: Chen, H-H
  organization: Department of Public Health and Institute of Epidemiology and Preventive Medicine, National Taiwan University
– sequence: 2
  givenname: Y J
  surname: Tseng
  fullname: Tseng, Y J
  organization: School of Pharmacy, College of Medicine, National Taiwan University, Department of Computer Science and Information Engineering, National Taiwan University, Graduate Institute of Biomedical Electronic and Bioinformatics, National Taiwan University, The Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University
– sequence: 3
  givenname: S-Y
  surname: Wang
  fullname: Wang, S-Y
  organization: Department of Computer Science and Information Engineering, National Taiwan University, The Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University
– sequence: 4
  givenname: Y-S
  surname: Tsai
  fullname: Tsai, Y-S
  organization: Institute of Clinical Medicine, National Cheng Kung University Medical College
– sequence: 5
  givenname: C-S
  surname: Chang
  fullname: Chang, C-S
  organization: Institute of Clinical Medicine, National Cheng Kung University Medical College, Department of Family Medicine, National Cheng Kung University Hospital
– sequence: 6
  givenname: T-C
  surname: Kuo
  fullname: Kuo, T-C
  organization: Graduate Institute of Biomedical Electronic and Bioinformatics, National Taiwan University, The Metabolomics Core Laboratory, Center of Genomic Medicine, National Taiwan University
– sequence: 7
  givenname: W-J
  surname: Yao
  fullname: Yao, W-J
  organization: Department of Nuclear Medicine, National Cheng Kung University Hospital
– sequence: 8
  givenname: C-C
  surname: Shieh
  fullname: Shieh, C-C
  organization: Institute of Clinical Medicine, National Cheng Kung University Medical College
– sequence: 9
  givenname: C-H
  surname: Wu
  fullname: Wu, C-H
  email: paulo@mail.ncku.edu.tw
  organization: Department of Family Medicine, National Cheng Kung University Hospital, Institute of Behavioral Medicine, National Cheng Kung University Medical College
– sequence: 10
  givenname: P-H
  surname: Kuo
  fullname: Kuo, P-H
  email: phkuo@ntu.edu.tw
  organization: Department of Public Health and Institute of Epidemiology and Preventive Medicine, National Taiwan University, Research Center for Genes, Environment and Human Health, National Taiwan University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25907313$$D View this record in MEDLINE/PubMed
BookMark eNqN0s1r1EAUAPBBKnZbPXmXgCAFzTofma9jKdUWCr1UPA6T5GV3lsnMmkmQ_PfOuq22pUrJITn83kfee0foIMQACL0leEkwU5_dJi4pJnwp-Au0IJUUJa-0PEALzLAsMRf8EB2ltMEYc47pK3RIucaSEbZA32_WUPQw2jr62EOxHWLnvAurwoa22Npx_dPO-dv6OblUuHCHXVOswfpxPf-Wtg5x6K0vYg3JjfNr9LKzPsGb2_cx-vbl_Obsory6_np5dnpVNlzqsQTQVFJdYQaiEyr3BDL_SsMBWsw6q1XHmBC1JtTWjVKVBdG20OlKYWx1xY7RyT5vbvzHBGk0vUsNeG8DxCkZIhlVVOQCz6CYYqWJkJm-f0Q3cRryEJKhjBFBuaTifyrnIlRVlFd_1cp6MC50cRxssyttTjNQhOQRZLV8QuWnhd41eeF5K_Aw4MO9gP0qUvTT6GJID-G72y6nuofWbAfX22E2dzeQwcc9aIaY0gDdH0Kw2V2YyRdmdhdmBM-aPNKNG-2uam7Y-X_EfNrHpJw5rGC4N6gn-C_Q4t2l
CitedBy_id crossref_primary_10_1039_C6FO00993J
crossref_primary_10_3389_fendo_2023_1151757
crossref_primary_10_1016_j_diabres_2021_109077
crossref_primary_10_1155_2016_2108909
crossref_primary_10_3389_fnins_2025_1498981
crossref_primary_10_1093_hmg_ddv375
crossref_primary_10_3390_molecules25112477
crossref_primary_10_3945_jn_115_219147
crossref_primary_10_3390_antiox13030302
crossref_primary_10_1002_oby_21724
crossref_primary_10_1039_D0FO01275K
crossref_primary_10_1371_journal_pone_0143190
crossref_primary_10_1534_genetics_117_300280
crossref_primary_10_3390_foods11193000
crossref_primary_10_1038_s41416_022_01873_9
crossref_primary_10_1038_s41598_023_39661_x
crossref_primary_10_1186_s12882_020_02164_2
crossref_primary_10_3390_metabo11070448
crossref_primary_10_1007_s12282_024_01579_1
crossref_primary_10_1016_j_isci_2020_100977
crossref_primary_10_3346_jkms_2020_35_e273
crossref_primary_10_1002_advs_202309525
crossref_primary_10_1177_1469066720964632
crossref_primary_10_13005_bpj_2274
crossref_primary_10_5812_jjnpp_107566
crossref_primary_10_1016_j_sjbs_2020_03_015
crossref_primary_10_1016_j_aquaculture_2018_03_050
crossref_primary_10_1021_acs_jproteome_1c00879
crossref_primary_10_18705_1607_419X_2021_27_3_279_290
crossref_primary_10_1007_s00204_023_03474_8
crossref_primary_10_1038_s41564_018_0146_2
crossref_primary_10_1039_C8FO02334D
crossref_primary_10_1371_journal_pone_0231506
crossref_primary_10_1089_cmb_2018_0185
crossref_primary_10_1093_advances_nmac103
crossref_primary_10_1134_S1061934819040051
crossref_primary_10_1186_s12986_016_0095_9
crossref_primary_10_2147_DMSO_S337979
crossref_primary_10_1186_s12944_020_01273_z
crossref_primary_10_3389_fendo_2021_761547
crossref_primary_10_1002_2211_5463_13788
crossref_primary_10_1007_s11886_020_01422_x
crossref_primary_10_3390_metabo12020161
crossref_primary_10_1021_acs_jproteome_7b00855
crossref_primary_10_1007_s40201_024_00912_2
crossref_primary_10_1039_C6FO01753C
crossref_primary_10_3390_ijms21134652
crossref_primary_10_3390_antiox11040774
crossref_primary_10_1016_j_rehab_2016_07_262
crossref_primary_10_1186_s12859_016_1292_2
crossref_primary_10_1038_s41598_018_33540_6
crossref_primary_10_1172_jci_insight_158037
crossref_primary_10_1002_oby_21482
crossref_primary_10_3389_fphys_2021_731762
crossref_primary_10_1002_oby_22694
crossref_primary_10_1161_JAHA_121_021369
crossref_primary_10_3390_metabo11060392
crossref_primary_10_1002_oby_22336
crossref_primary_10_3390_nu8060324
crossref_primary_10_3390_biomedicines10112891
crossref_primary_10_1186_s12859_016_1335_8
crossref_primary_10_1016_j_diabres_2015_12_024
crossref_primary_10_1007_s40200_021_00917_w
crossref_primary_10_1210_clinem_dgac160
crossref_primary_10_1038_srep30958
crossref_primary_10_1080_02652048_2022_2061058
crossref_primary_10_1007_s10695_019_00669_8
crossref_primary_10_1155_2022_2739772
crossref_primary_10_3389_fmolb_2023_1166333
crossref_primary_10_1017_S0007114522003385
crossref_primary_10_3390_toxics12040288
crossref_primary_10_3390_nu16203501
crossref_primary_10_1016_j_cmet_2018_09_022
crossref_primary_10_1016_j_tem_2017_07_001
crossref_primary_10_3168_jds_2019_17114
crossref_primary_10_1016_j_lfs_2023_122180
crossref_primary_10_1021_acs_jafc_8b00421
crossref_primary_10_1016_j_clnu_2019_04_025
crossref_primary_10_3390_metabo12080677
crossref_primary_10_1016_j_psj_2020_05_025
crossref_primary_10_1007_s11306_016_1114_6
crossref_primary_10_1097_FJC_0000000000000776
crossref_primary_10_1039_C6RA28715H
crossref_primary_10_1016_j_aqrep_2019_100271
crossref_primary_10_1038_ijo_2017_288
crossref_primary_10_2147_DMSO_S294894
crossref_primary_10_1016_j_phymed_2024_156355
crossref_primary_10_1111_nmo_13178
crossref_primary_10_3389_fcdhc_2022_980856
crossref_primary_10_2147_DDDT_S379335
crossref_primary_10_1097_NNR_0000000000000783
crossref_primary_10_4239_wjd_v12_i4_420
crossref_primary_10_1007_s00508_022_02146_4
crossref_primary_10_2147_DMSO_S301363
crossref_primary_10_3389_fendo_2021_637317
crossref_primary_10_1021_acs_jproteome_7b00802
crossref_primary_10_1111_dom_15395
crossref_primary_10_1038_s41598_017_02856_0
crossref_primary_10_3390_metabo13050641
Cites_doi 10.1161/CIRCULATIONAHA.111.027375
10.1038/nm.2307
10.1021/bi00249a015
10.1016/j.atherosclerosis.2008.05.022
10.1007/s00125-009-1637-8
10.1007/S11745-000-0593-z
10.2337/DC11-1577
10.1039/b914182k
10.1042/BJ20060221
10.2337/dc12-1971
10.1001/archinte.165.7.742
10.1097/AOG.0b013e318255004e
10.1001/jama.282.16.1519
10.1210/jc.2007-2724
10.1038/ijo.2010.44
10.1001/archinte.168.15.1617
10.5936/csbj.201301009
10.1016/j.jchromb.2011.08.014
10.1152/ajpregu.00103.2004
10.1152/ajpcell.1997.272.1.C289
10.1371/journal.pone.0010883
10.1016/j.abb.2008.10.011
10.1038/nature07540
10.1172/JCI63967
10.1210/jc.2014-3157
10.1111/j.1523-1755.2004.00963.x
10.1016/j.bbabio.2012.11.014
10.1007/s11695-008-9521-z
10.1093/nar/gkr988
10.1210/jc.2011-3475
10.2337/db06-0062
10.1016/S1590-8658(00)80825-7
10.1038/oby.2009.510
10.1023/A:1027332523114
10.1093/ajcn/86.6.1687
10.1016/j.nutres.2010.09.007
10.1210/jc.2005-0482
10.1016/j.braindev.2010.06.016
10.1159/000343204
10.1016/j.cmet.2009.02.002
10.1021/bi9722507
10.1089/109662002753723197
10.1042/bj3200345
10.1053/j.gastro.2008.09.018
10.1021/pr100101p
10.2337/dc09-0574
10.2337/diacare.27.5.1182
10.1038/msb.2008.50
10.1038/nrendo.2014.171
10.1111/j.1463-1326.2008.00866.x
10.1016/j.amjhyper.2006.06.015
10.1053/j.ajkd.2006.09.004
10.1002/jms.3154
10.1007/s11306-012-0434-4
10.1152/physiolgenomics.00194.2006
10.2337/diabetes.54.1.8
10.2337/db13-0719
10.1093/bioinformatics/btq418
ContentType Journal Article
Copyright Macmillan Publishers Limited 2015
COPYRIGHT 2015 Nature Publishing Group
Copyright Nature Publishing Group Aug 2015
Macmillan Publishers Limited 2015.
Copyright_xml – notice: Macmillan Publishers Limited 2015
– notice: COPYRIGHT 2015 Nature Publishing Group
– notice: Copyright Nature Publishing Group Aug 2015
– notice: Macmillan Publishers Limited 2015.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7T2
7TK
7TS
7X2
7X7
7XB
88E
88G
8AO
8C1
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
ATCPS
AZQEC
BBNVY
BENPR
BHPHI
C1K
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0K
M0S
M1P
M2M
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PSYQQ
Q9U
7X8
DOI 10.1038/ijo.2015.65
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health and Safety Science Abstracts (Full archive)
Neurosciences Abstracts
Physical Education Index
Agricultural Science Collection
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
ProQuest Pharma Collection
Public Health Database
ProQuest SciTech Collection
ProQuest Natural Science Collection
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability (subscription)
ProQuest Central UK/Ireland
ProQuest Agricultural & Environmental Science & Pollution Managment
ProQuest Central Essentials
Biological Science Collection
Proquest Central
Natural Science Collection
Environmental Sciences and Pollution Management
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
Biological Sciences
Agricultural Science Database
ProQuest Health & Medical Collection
PML(ProQuest Medical Library)
Psychology Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest One Psychology
ProQuest Central Basic
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Agricultural Science Database
ProQuest One Psychology
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Pharma Collection
Physical Education Index
Environmental Sciences and Pollution Management
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Agricultural & Environmental Science Collection
Biological Science Collection
Health & Safety Science Abstracts
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Public Health
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest One Academic Eastern Edition
Agricultural Science Collection
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
Biological Science Database
ProQuest SciTech Collection
Neurosciences Abstracts
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest Psychology Journals
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE

Agricultural Science Database

Physical Education Index


MEDLINE - Academic
Agricultural Science Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Public Health
Diet & Clinical Nutrition
Recreation & Sports
EISSN 1476-5497
EndPage 1248
ExternalDocumentID 3767656231
A425811927
25907313
10_1038_ijo_2015_65
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Taiwan
GeographicLocations_xml – name: Taiwan
GroupedDBID .55
.GJ
29J
36B
39C
5RE
7X2
7X7
8R4
8R5
A8Z
ABDBF
ABOCM
ABUWG
ACUHS
ADBBV
AFFNX
AI.
ALMA_UNASSIGNED_HOLDINGS
ATCPS
AZQEC
B0M
BAWUL
BENPR
BHPHI
BPHCQ
DIK
DWQXO
EAD
EAP
EBC
EBD
EBS
EMB
EMK
EMOBN
EPL
ESX
F5P
FYUFA
GNUQQ
HCIFZ
IAO
IHR
ITC
J5H
M0K
M1P
M2M
MVM
NAO
OK1
Q2X
RNT
RNTTT
SV3
TUS
VH1
WH7
X7M
ZGI
ZXP
~8M
AAYXX
CITATION
---
-Q-
..I
.L3
.XZ
0R~
1CY
2FS
2WC
4.4
406
53G
5GY
70F
88E
8AO
8C1
8FE
8FH
8FI
8FJ
AACDK
AAHBH
AANZL
AASML
AATNV
AAWTL
AAYZH
ABAKF
ABAWZ
ABBRH
ABCQX
ABDBE
ABFSG
ABIVO
ABJNI
ABLJU
ABRTQ
ABZZP
ACAOD
ACGFS
ACKTT
ACPRK
ACRQY
ACSTC
ACZOJ
ADHUB
ADXHL
AEFQL
AEJRE
AEMSY
AENEX
AEUYN
AEVLU
AEXYK
AEZWR
AFBBN
AFDZB
AFHIU
AFKRA
AFRAH
AFSHS
AGAYW
AGHAI
AGQEE
AHMBA
AHSBF
AHWEU
AIGIU
AILAN
AIXLP
AJRNO
ALFFA
ALIPV
AMYLF
APEBS
ATHPR
AXYYD
AYFIA
BBNVY
BKKNO
BVXVI
CCPQU
CGR
CS3
CUY
CVF
DNIVK
DPUIP
DU5
E3Z
EBLON
ECM
EE.
EIF
EIOEI
EJD
FDQFY
FERAY
FIGPU
FIZPM
FSGXE
HMCUK
HZ~
IHW
INH
INR
IPY
IWAJR
JSO
JZLTJ
KQ8
L7B
M7P
NPM
NQJWS
O9-
OVD
P2P
P6G
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
PQQKQ
PROAC
PSQYO
PSYQQ
RNS
ROL
SNX
SNYQT
SOHCF
SOJ
SRMVM
SWTZT
TAOOD
TBHMF
TDRGL
TEORI
TR2
TSG
UKHRP
~KM
3V.
7T2
7TK
7TS
7XB
8FK
C1K
K9.
LK8
PKEHL
PQEST
PQUKI
Q9U
7X8
ID FETCH-LOGICAL-c579t-ee92729403e6f68731e7015c5eed03fa98f3366b912abc884ae6ddef94800a943
IEDL.DBID 7X7
ISSN 0307-0565
1476-5497
IngestDate Fri Jul 11 07:07:43 EDT 2025
Fri Jul 11 00:52:40 EDT 2025
Thu Jul 17 02:13:47 EDT 2025
Wed Jul 16 16:06:30 EDT 2025
Tue Jun 17 21:40:17 EDT 2025
Tue Jun 10 20:12:18 EDT 2025
Thu May 22 21:17:52 EDT 2025
Mon Jul 21 06:01:38 EDT 2025
Tue Jul 01 03:01:54 EDT 2025
Thu Apr 24 22:58:28 EDT 2025
Fri Feb 21 02:39:11 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c579t-ee92729403e6f68731e7015c5eed03fa98f3366b912abc884ae6ddef94800a943
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 25907313
PQID 1701284254
PQPubID 38864
PageCount 8
ParticipantIDs proquest_miscellaneous_1732826403
proquest_miscellaneous_1702089167
proquest_journals_2331625726
proquest_journals_1701284254
gale_infotracmisc_A425811927
gale_infotracacademiconefile_A425811927
gale_healthsolutions_A425811927
pubmed_primary_25907313
crossref_primary_10_1038_ijo_2015_65
crossref_citationtrail_10_1038_ijo_2015_65
springer_journals_10_1038_ijo_2015_65
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-08-01
PublicationDateYYYYMMDD 2015-08-01
PublicationDate_xml – month: 08
  year: 2015
  text: 2015-08-01
  day: 01
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationSubtitle Official journal of the International Association for the Study of Obesity
PublicationTitle International Journal of Obesity
PublicationTitleAbbrev Int J Obes
PublicationTitleAlternate Int J Obes (Lond)
PublicationYear 2015
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Mokdad, Serdula, Dietz, Bowman, Marks, Koplan (CR1) 1999; 282
Lee, Chang, Chiang, Liu, Yeh, Chen (CR47) 2011; 124
Brochu, Tchernof, Dionne, Sites, Eltabbakh, Sims (CR7) 2001; 86
Connor, Hansen, Corner, Smith, Ryan (CR9) 2010; 6
Kirchberg, Harder, Weber, Grote, Demmelmair, Peissner (CR28) 2015; 100
Turnbaugh, Hamady, Yatsunenko, Cantarel, Duncan, Ley (CR60) 2009; 457
Nilsen, Bjorke-Monsen, Midttun, Nygard, Pedersen, Ulvik (CR48) 2012; 119
Bartel, Krumsiek, Theis (CR18) 2013; 4
Wahl, Yu, Kleber, Singmann, Holzapfel, He (CR25) 2012; 5
Tai, Tan, Stevens, Low, Muehlbauer, Goh (CR26) 2010; 53
Shaham, Wei, Wang, Ricciardi, Lewis, Vasan (CR27) 2008; 4
Kuk, Ardern (CR16) 2009; 32
Dweikat, Naser, Abu Libdeh, Naser, Abu Gharbieh, Maraqa (CR33) 2011; 33
Konrad, Major, Wolf (CR50) 1994; 33
Wang, Feng, Sun, Li, Bi, Sun (CR14) 2011; 879
Schwab, Sauer, Okun, Nijtmans, Rodenburg, van den Heuvel (CR32) 2006; 398
Appleton, Seaborn, Visvanathan, Hill, Gill, Taylor (CR5) 2013; 36
Lara Baruque, Razquin, Jimenez, Vazquez, Gisbert, Pajares (CR45) 2000; 32
Levin (CR55) 2002; 5
Walsh, Brennan, Pujos-Guillot, Sebedio, Scalbert, Fagan (CR61) 2007; 86
Mihalik, Goodpaster, Kelley, Chace, Vockley, Toledo (CR12) 2009; 18
Coutinho Tde, Turner, Peyser, Bielak, Sheedy, Kullo (CR54) 2007; 20
Aguilar-Salinas, Garcia, Robles, Riano, Ruiz-Gomez, Garcia-Ulloa (CR2) 2008; 93
Lynch, Adams (CR30) 2014; 10
Wildman, Muntner, Reynolds, McGinn, Rajpathak, Wylie-Rosett (CR3) 2008; 168
Foster (CR34) 2012; 122
Ritov, Menshikova, He, Ferrell, Goodpaster, Kelley (CR31) 2005; 54
Bandyopadhyay, Yu, Ofrecio, Olefsky (CR35) 2006; 55
Karelis, Faraj, Bastard, St-Pierre, Brochu, Prud'homme (CR6) 2005; 90
Mracek, Pecinova, Vrbacky, Drahota, Houstek (CR39) 2009; 481
Eaton, Bartlett, Pourfarzam (CR22) 1996; 320
Alfadda, DosSantos, Stepanyan, Marrif, Silva (CR38) 2004; 287
Salek, Maguire, Bentley, Rubtsov, Hough, Cheeseman (CR59) 2007; 29
Swierczynski, Zabrocka, Goyke, Raczynska, Adamonis, Sledzinski (CR37) 2003; 254
Hamer, Stamatakis (CR4) 2012; 97
Kim, Park, Kim, Ham, Kim, Kwon (CR11) 2010; 9
Choi, Atkinson, Karlson, Curhan (CR53) 2005; 165
Kanehisa, Goto, Sato, Furumichi, Tanabe (CR20) 2011; 40
Calvani, Miccheli, Capuani, Tomassini Miccheli, Puccetti, Delfini (CR58) 2010; 34
Gu, A, Wang, Zha, Yan, Zhang (CR10) 2010; 24
Gall, Beebe, Lawton, Adam, Mitchell, Nakhle (CR23) 2010; 5
Wang, Larson, Vasan, Cheng, Rhee, McCabe (CR29) 2011; 17
Ramanadham, Hsu, Bohrer, Nowatzke, Ma, Turk (CR49) 1998; 37
Hsu, Bohrer, Wohltmann, Ramanadham, Ma, Yarasheski (CR51) 2000; 35
Dunn, Erban, Weber, Creek, Brown, Breitling (CR19) 2012; 9
Youn, Siu, Lob, Itani, Harrison, Cai (CR40) 2014; 63
Lu, Levin, Tagatose Donner (CR57) 2008; 10
Xia, Wishart (CR21) 2010; 26
Gagliardi, Miname, Santos (CR52) 2009; 202
Preet, Karve, Rizk, Cheema (CR8) 2012; S6
Cao, Honeyman, Cooney, Kennington, Scheid, Jonassen (CR42) 2004; 66
Newgard, An, Bain, Muehlbauer, Stevens, Lien (CR24) 2009; 9
Poore, Hurst, Assimos, Holmes (CR41) 1997; 272
Mracek, Drahota, Houstek (CR36) 2013; 1827
Ho, Kuo, Wang, Chen, Tseng (CR17) 2013; 48
Swierczynski, Sledzinski, Slominska, Smolenski, Sledzinski (CR44) 2008; 19
Mihalik, Michaliszyn, de Las Heras, Bacha, Lee, Chace (CR13) 2012; 35
Goessling, Massaro, Vasan, D'Agostino, Ellison, Fox (CR46) 2008; 135
Donner, Magder, Zarbalian (CR56) 2010; 30
Tan, Ma, Wai, Chew, Tai (CR15) 2004; 27
Taylor, Curhan (CR43) 2006; 48
M Kanehisa (BFijo201565_CR20) 2011; 40
O Shaham (BFijo201565_CR27) 2008; 4
R Calvani (BFijo201565_CR58) 2010; 34
JL Kuk (BFijo201565_CR16) 2009; 32
RP Wildman (BFijo201565_CR3) 2008; 168
A Preet (BFijo201565_CR8) 2012; S6
S Gu (BFijo201565_CR10) 2010; 24
Y Lu (BFijo201565_CR57) 2008; 10
M Hamer (BFijo201565_CR4) 2012; 97
S Wahl (BFijo201565_CR25) 2012; 5
AH Mokdad (BFijo201565_CR1) 1999; 282
J Swierczynski (BFijo201565_CR44) 2008; 19
DW Foster (BFijo201565_CR34) 2012; 122
RJ Konrad (BFijo201565_CR50) 1994; 33
M Brochu (BFijo201565_CR7) 2001; 86
SC Connor (BFijo201565_CR9) 2010; 6
VB Ritov (BFijo201565_CR31) 2005; 54
JY Kim (BFijo201565_CR11) 2010; 9
J Bartel (BFijo201565_CR18) 2013; 4
A Alfadda (BFijo201565_CR38) 2004; 287
FF Kirchberg (BFijo201565_CR28) 2015; 100
RM Nilsen (BFijo201565_CR48) 2012; 119
S Ramanadham (BFijo201565_CR49) 1998; 37
L-C Cao (BFijo201565_CR42) 2004; 66
EN Taylor (BFijo201565_CR43) 2006; 48
SJ Mihalik (BFijo201565_CR13) 2012; 35
FF Hsu (BFijo201565_CR51) 2000; 35
SL Appleton (BFijo201565_CR5) 2013; 36
C Wang (BFijo201565_CR14) 2011; 879
A Coutinho Tde (BFijo201565_CR54) 2007; 20
MC Walsh (BFijo201565_CR61) 2007; 86
S Eaton (BFijo201565_CR22) 1996; 320
IM Dweikat (BFijo201565_CR33) 2011; 33
PJ Turnbaugh (BFijo201565_CR60) 2009; 457
RM Salek (BFijo201565_CR59) 2007; 29
J Xia (BFijo201565_CR21) 2010; 26
S Lara Baruque (BFijo201565_CR45) 2000; 32
ACM Gagliardi (BFijo201565_CR52) 2009; 202
ES Tai (BFijo201565_CR26) 2010; 53
HK Choi (BFijo201565_CR53) 2005; 165
T Mracek (BFijo201565_CR39) 2009; 481
C-E Tan (BFijo201565_CR15) 2004; 27
AD Karelis (BFijo201565_CR6) 2005; 90
WB Dunn (BFijo201565_CR19) 2012; 9
MA Schwab (BFijo201565_CR32) 2006; 398
T Mracek (BFijo201565_CR36) 2013; 1827
W Goessling (BFijo201565_CR46) 2008; 135
WE Gall (BFijo201565_CR23) 2010; 5
RE Poore (BFijo201565_CR41) 1997; 272
TW Donner (BFijo201565_CR56) 2010; 30
GV Levin (BFijo201565_CR55) 2002; 5
GK Bandyopadhyay (BFijo201565_CR35) 2006; 55
J Swierczynski (BFijo201565_CR37) 2003; 254
YC Lee (BFijo201565_CR47) 2011; 124
JY Youn (BFijo201565_CR40) 2014; 63
CA Aguilar-Salinas (BFijo201565_CR2) 2008; 93
TJ Wang (BFijo201565_CR29) 2011; 17
SJ Mihalik (BFijo201565_CR12) 2009; 18
CJ Lynch (BFijo201565_CR30) 2014; 10
CB Newgard (BFijo201565_CR24) 2009; 9
TJ Ho (BFijo201565_CR17) 2013; 48
11238480 - J Clin Endocrinol Metab. 2001 Mar;86(3):1020-5
16686602 - Biochem J. 2006 Aug 15;398(1):107-12
17941870 - Diabetes Obes Metab. 2008 Feb;10 (2):109-34
21147362 - Nutr Res. 2010 Dec;30(12 ):801-6
15855252 - J Clin Endocrinol Metab. 2005 Jul;90(7):4145-50
20111019 - Obesity (Silver Spring). 2010 Sep;18(9):1695-700
20526369 - PLoS One. 2010 May 28;5(5):e10883
7947736 - Biochemistry. 1994 Nov 15;33(45):13284-94
17190852 - Physiol Genomics. 2007 Apr 24;29(2):99-108
20567778 - Mol Biosyst. 2010 May;6(5):909-21
12511110 - J Med Food. 2002 Spring;5(1):23-36
24688690 - Comput Struct Biotechnol J. 2013 Mar 22;4:e201301009
22508708 - J Clin Endocrinol Metab. 2012 Jul;97(7):2482-8
18952046 - Arch Biochem Biophys. 2009 Jan 1;481(1):30-6
24550188 - Diabetes. 2014 Jul;63(7):2344-55
21844078 - Circulation. 2011 Sep 6;124(10 ):1160-71
9521776 - Biochemistry. 1998 Mar 31;37(13):4553-67
19043404 - Nature. 2009 Jan 22;457(7228):480-4
23491523 - Diabetes Care. 2013 Aug;36(8):2388-94
22080510 - Nucleic Acids Res. 2012 Jan;40(Database issue):D109-14
15031134 - Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R147-56
15824292 - Arch Intern Med. 2005 Apr 11;165(7):742-8
20212498 - Int J Obes (Lond). 2010 Jun;34(6):1095-8
19729521 - Diabetes Care. 2009 Dec;32(12):2297-9
25287287 - Nat Rev Endocrinol. 2014 Dec;10(12):723-36
19010326 - Gastroenterology. 2008 Dec;135(6):1935-44, 1944.e1
20628077 - Bioinformatics. 2010 Sep 15;26(18):2342-4
18431611 - Obes Surg. 2009 Jul;19(7):883-9
23220394 - Biochim Biophys Acta. 2013 Mar;1827(3):401-10
18682704 - Mol Syst Biol. 2008;4:214
17162145 - Am J Kidney Dis. 2006 Dec;48(6):905-15
21423183 - Nat Med. 2011 Apr;17(4):448-53
15616005 - Diabetes. 2005 Jan;54(1):8-14
20076942 - Diabetologia. 2010 Apr;53(4):757-67
8973539 - Biochem J. 1996 Dec 1;320 ( Pt 2):345-57
18695075 - Arch Intern Med. 2008 Aug 11;168(15):1617-24
14674682 - Mol Cell Biochem. 2003 Dec;254(1-2):55-9
25368978 - J Clin Endocrinol Metab. 2015 Jan;100(1):149-58
22833869 - J Clin Invest. 2012 Jun;122(6):1958-9
23108202 - Obes Facts. 2012;5(5):660-70
18065587 - Am J Clin Nutr. 2007 Dec;86(6):1687-93
23378096 - J Mass Spectrom. 2013 Feb;48(2):234-42
22266733 - Diabetes Care. 2012 Mar;35(3):605-11
15111542 - Diabetes Care. 2004 May;27(5):1182-6
9038835 - Am J Physiol. 1997 Jan;272(1 Pt 1):C289-94
10984107 - Lipids. 2000 Aug;35(8):839-54
10546690 - JAMA. 1999 Oct 27;282(16):1519-22
21890434 - J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Oct 1;879(27):2871-6
19356713 - Cell Metab. 2009 Apr;9(4):311-26
19606418 - Biomed Chromatogr. 2010 Mar;24(3):245-52
18585721 - Atherosclerosis. 2009 Jan;202(1):11-7
18682512 - J Clin Endocrinol Metab. 2008 Oct;93(10):4075-9
10975773 - Dig Liver Dis. 2000 Apr;32(3):226-32
17198917 - Am J Hypertens. 2007 Jan;20(1):83-9
16873691 - Diabetes. 2006 Aug;55(8):2277-85
22617590 - Obstet Gynecol. 2012 Jun;119(6):1243-50
20634010 - Brain Dev. 2011 May;33(5):428-31
15496160 - Kidney Int. 2004 Nov;66(5):1890-900
20560578 - J Proteome Res. 2010 Sep 3;9(9):4368-75
References_xml – volume: 124
  start-page: 1160
  year: 2011
  end-page: 1171
  ident: CR47
  article-title: Role of Perivascular Adipose Tissue-Derived Methyl Palmitate in Vascular Tone Regulation and Pathogenesis of Hypertension
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.027375
– volume: 17
  start-page: 448
  year: 2011
  end-page: 453
  ident: CR29
  article-title: Metabolite profiles and the risk of developing diabetes
  publication-title: Nat Med
  doi: 10.1038/nm.2307
– volume: 33
  start-page: 13284
  year: 1994
  end-page: 13294
  ident: CR50
  article-title: Diacylglycerol hydrolysis to arachidonic acid is necessary for insulin secretion from isolated pancreatic islets: sequential actions of diacylglycerol and monoacylglycerol lipases
  publication-title: Biochemistry
  doi: 10.1021/bi00249a015
– volume: 202
  start-page: 11
  year: 2009
  end-page: 17
  ident: CR52
  article-title: Uric acid: a marker of increased cardiovascular risk
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2008.05.022
– volume: 53
  start-page: 757
  year: 2010
  end-page: 767
  ident: CR26
  article-title: Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men
  publication-title: Diabetologia
  doi: 10.1007/s00125-009-1637-8
– volume: 35
  start-page: 839
  year: 2000
  end-page: 854
  ident: CR51
  article-title: Electrospray ionization mass spectrometric analyses of changes in tissue phospholipid molecular species during the evolution of hyperlipidemia and hyperglycemia in Zucker diabetic fatty rats
  publication-title: Lipids
  doi: 10.1007/S11745-000-0593-z
– volume: 35
  start-page: 605
  year: 2012
  end-page: 611
  ident: CR13
  article-title: Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation
  publication-title: Diabetes Care
  doi: 10.2337/DC11-1577
– volume: 6
  start-page: 909
  year: 2010
  ident: CR9
  article-title: Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes
  publication-title: Mol BioSyst
  doi: 10.1039/b914182k
– volume: 398
  start-page: 107
  year: 2006
  end-page: 112
  ident: CR32
  article-title: Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins
  publication-title: Biochem J
  doi: 10.1042/BJ20060221
– volume: 36
  start-page: 2388
  year: 2013
  end-page: 2394
  ident: CR5
  article-title: Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study
  publication-title: Diabetes Care
  doi: 10.2337/dc12-1971
– volume: 165
  start-page: 742
  year: 2005
  end-page: 748
  ident: CR53
  article-title: Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.165.7.742
– volume: 119
  start-page: 1243
  year: 2012
  end-page: 1250
  ident: CR48
  article-title: Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia
  publication-title: Obstet Gynecol
  doi: 10.1097/AOG.0b013e318255004e
– volume: 282
  start-page: 1519
  year: 1999
  end-page: 1522
  ident: CR1
  article-title: The spread of the obesity epidemic in the United States, 1991-1998
  publication-title: JAMA
  doi: 10.1001/jama.282.16.1519
– volume: 93
  start-page: 4075
  year: 2008
  end-page: 4079
  ident: CR2
  article-title: High adiponectin concentrations are associated with the metabolically healthy obese phenotype
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-2724
– volume: 34
  start-page: 1095
  year: 2010
  end-page: 1098
  ident: CR58
  article-title: Gut microbiome-derived metabolites characterize a peculiar obese urinary metabotype
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2010.44
– volume: 168
  start-page: 1617
  year: 2008
  end-page: 1624
  ident: CR3
  article-title: The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.168.15.1617
– volume: 4
  start-page: e201301009
  year: 2013
  ident: CR18
  article-title: Statistical methods for the analysis of high-throughput metabolomics data
  publication-title: Comput Struct Biotechnol J
  doi: 10.5936/csbj.201301009
– volume: 879
  start-page: 2871
  year: 2011
  end-page: 2876
  ident: CR14
  article-title: Metabolic profiling of urine in young obese men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC/Q-TOF MS)
  publication-title: J Chromatogr B Analyt Technol Biomed Life Sci
  doi: 10.1016/j.jchromb.2011.08.014
– volume: 287
  start-page: R147
  year: 2004
  end-page: R156
  ident: CR38
  article-title: Mice with deletion of the mitochondrial glycerol-3-phosphate dehydrogenase gene exhibit a thrifty phenotype: effect of gender
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00103.2004
– volume: 272
  start-page: C289
  year: 1997
  end-page: C294
  ident: CR41
  article-title: Pathways of hepatic oxalate synthesis and their regulation
  publication-title: Am J Physiol
  doi: 10.1152/ajpcell.1997.272.1.C289
– volume: 5
  start-page: e10883
  year: 2010
  ident: CR23
  article-title: α-Hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0010883
– volume: 481
  start-page: 30
  year: 2009
  end-page: 36
  ident: CR39
  article-title: High efficiency of ROS production by glycerophosphate dehydrogenase in mammalian mitochondria
  publication-title: Arch Biochem Biophys
  doi: 10.1016/j.abb.2008.10.011
– volume: 457
  start-page: 480
  year: 2009
  end-page: 484
  ident: CR60
  article-title: A core gut microbiome in obese and lean twins
  publication-title: Nature
  doi: 10.1038/nature07540
– volume: 122
  start-page: 1958
  year: 2012
  end-page: 1959
  ident: CR34
  article-title: Malonyl-CoA: the regulator of fatty acid synthesis and oxidation
  publication-title: J Clin Invest
  doi: 10.1172/JCI63967
– volume: 100
  start-page: 149
  year: 2015
  end-page: 158
  ident: CR28
  article-title: Dietary protein intake affects amino Acid and acylcarnitine metabolism in infants aged 6 months
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2014-3157
– volume: 66
  start-page: 1890
  year: 2004
  end-page: 1900
  ident: CR42
  article-title: Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2004.00963.x
– volume: 1827
  start-page: 401
  year: 2013
  end-page: 410
  ident: CR36
  article-title: The function and the role of the mitochondrial glycerol-3-phosphate dehydrogenase in mammalian tissues
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbabio.2012.11.014
– volume: 19
  start-page: 883
  year: 2008
  end-page: 889
  ident: CR44
  article-title: Serum phenylalanine concentration as a marker of liver function in obese patients before and after bariatric surgery
  publication-title: Obes Surg
  doi: 10.1007/s11695-008-9521-z
– volume: 40
  start-page: D109
  year: 2011
  end-page: D114
  ident: CR20
  article-title: KEGG for integration and interpretation of large-scale molecular data sets
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkr988
– volume: 97
  start-page: 2482
  year: 2012
  end-page: 2488
  ident: CR4
  article-title: Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-3475
– volume: 55
  start-page: 2277
  year: 2006
  end-page: 2285
  ident: CR35
  article-title: Increased malonyl-CoA levels in muscle from obese and type 2 diabetic subjects lead to decreased fatty acid oxidation and increased lipogenesis; thiazolidinedione treatment reverses these defects
  publication-title: Diabetes
  doi: 10.2337/db06-0062
– volume: 32
  start-page: 226
  year: 2000
  end-page: 232
  ident: CR45
  article-title: 13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease
  publication-title: Dig Liver Dis
  doi: 10.1016/S1590-8658(00)80825-7
– volume: 18
  start-page: 1695
  year: 2009
  end-page: 1700
  ident: CR12
  article-title: Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2009.510
– volume: 254
  start-page: 55
  year: 2003
  end-page: 59
  ident: CR37
  article-title: Enhanced glycerol 3-phosphate dehydrogenase activity in adipose tissue of obese humans
  publication-title: Mol Cell Biochem
  doi: 10.1023/A:1027332523114
– volume: 86
  start-page: 1687
  year: 2007
  end-page: 1693
  ident: CR61
  article-title: Influence of acute phytochemical intake on human urinary metabolomic profiles
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/86.6.1687
– volume: 30
  start-page: 801
  year: 2010
  end-page: 806
  ident: CR56
  article-title: Dietary supplementation with d-tagatose in subjects with type 2 diabetes leads to weight loss and raises high-density lipoprotein cholesterol
  publication-title: Nutr Res
  doi: 10.1016/j.nutres.2010.09.007
– volume: 90
  start-page: 4145
  year: 2005
  end-page: 4150
  ident: CR6
  article-title: The metabolically healthy but obese individual presents a favorable inflammation profile
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-0482
– volume: 33
  start-page: 428
  year: 2011
  end-page: 431
  ident: CR33
  article-title: Propionic acidemia mimicking diabetic ketoacidosis
  publication-title: Brain Dev
  doi: 10.1016/j.braindev.2010.06.016
– volume: 5
  start-page: 660
  year: 2012
  end-page: 670
  ident: CR25
  article-title: Childhood obesity is associated with changes in the serum metabolite profile
  publication-title: Obes Facts
  doi: 10.1159/000343204
– volume: 9
  start-page: 311
  year: 2009
  end-page: 326
  ident: CR24
  article-title: A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2009.02.002
– volume: 37
  start-page: 4553
  year: 1998
  end-page: 4567
  ident: CR49
  article-title: Electrospray ionization mass spectrometric analyses of phospholipids from rat and human pancreatic islets and subcellular membranes: comparison to other tissues and implications for membrane fusion in insulin exocytosis
  publication-title: Biochemistry
  doi: 10.1021/bi9722507
– volume: 5
  start-page: 23
  year: 2002
  end-page: 36
  ident: CR55
  article-title: Tagatose, the new GRAS sweetener and health product
  publication-title: J Med Food
  doi: 10.1089/109662002753723197
– volume: 320
  start-page: 345
  year: 1996
  end-page: 357
  ident: CR22
  article-title: Mammalian mitochondrial beta-oxidation
  publication-title: Biochem J
  doi: 10.1042/bj3200345
– volume: 135
  start-page: 1935
  year: 2008
  end-page: 1944
  ident: CR46
  article-title: Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.09.018
– volume: 9
  start-page: 4368
  year: 2010
  end-page: 4375
  ident: CR11
  article-title: Metabolic profiling of plasma in overweight/obese and lean men using ultra performance liquid chromatography and Q-TOF mass spectrometry (UPLC-Q-TOF MS)
  publication-title: J Proteome Res
  doi: 10.1021/pr100101p
– volume: 32
  start-page: 2297
  year: 2009
  end-page: 2299
  ident: CR16
  article-title: Are metabolically normal but obese individuals at lower risk for all-cause mortality?
  publication-title: Diabetes Care
  doi: 10.2337/dc09-0574
– volume: 27
  start-page: 1182
  year: 2004
  end-page: 1186
  ident: CR15
  article-title: Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.5.1182
– volume: 4
  start-page: 214
  year: 2008
  ident: CR27
  article-title: Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity
  publication-title: Mol Syst Biol
  doi: 10.1038/msb.2008.50
– volume: 24
  start-page: 242
  year: 2010
  end-page: 252
  ident: CR10
  article-title: Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia
  publication-title: Biomed Chromatogr
– volume: 10
  start-page: 723
  year: 2014
  end-page: 736
  ident: CR30
  article-title: Branched-chain amino acids in metabolic signalling and insulin resistance
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2014.171
– volume: 86
  start-page: 1020
  year: 2001
  end-page: 1025
  ident: CR7
  article-title: What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
  publication-title: J Clin Endocrinol Metab
– volume: 10
  start-page: 109
  year: 2008
  end-page: 134
  ident: CR57
  article-title: a new antidiabetic and obesity control drug
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2008.00866.x
– volume: 20
  start-page: 83
  year: 2007
  end-page: 89
  ident: CR54
  article-title: Associations of serum uric acid with markers of inflammation, metabolic syndrome, and subclinical coronary atherosclerosis
  publication-title: Am J Hypertens
  doi: 10.1016/j.amjhyper.2006.06.015
– volume: S6
  start-page: 001
  year: 2012
  ident: CR8
  article-title: Metabolomics: approaches and applications to diabetes research
  publication-title: J Diabetes Metab
– volume: 48
  start-page: 905
  year: 2006
  end-page: 915
  ident: CR43
  article-title: Body size and 24-hour urine composition
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2006.09.004
– volume: 48
  start-page: 234
  year: 2013
  end-page: 242
  ident: CR17
  article-title: True ion pick (TIPick): a denoising and peak picking algorithm to extract ion signals from liquid chromatography/mass spectrometry data
  publication-title: J Mass Spectrom
  doi: 10.1002/jms.3154
– volume: 9
  start-page: 44
  year: 2012
  end-page: 66
  ident: CR19
  article-title: Mass appeal: metabolite identification in mass spectrometry-focused untargeted metabolomics
  publication-title: Metabolomics
  doi: 10.1007/s11306-012-0434-4
– volume: 29
  start-page: 99
  year: 2007
  end-page: 108
  ident: CR59
  article-title: A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human
  publication-title: Physiol Genomics
  doi: 10.1152/physiolgenomics.00194.2006
– volume: 54
  start-page: 8
  year: 2005
  end-page: 14
  ident: CR31
  article-title: Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.1.8
– volume: 63
  start-page: 2344
  year: 2014
  end-page: 2355
  ident: CR40
  article-title: Role of vascular oxidative stress in obesity and metabolic syndrome
  publication-title: Diabetes
  doi: 10.2337/db13-0719
– volume: 26
  start-page: 2342
  year: 2010
  end-page: 2344
  ident: CR21
  article-title: MetPA: a web-based metabolomics tool for pathway analysis and visualization
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq418
– volume: 17
  start-page: 448
  year: 2011
  ident: BFijo201565_CR29
  publication-title: Nat Med
  doi: 10.1038/nm.2307
– volume: S6
  start-page: 001
  year: 2012
  ident: BFijo201565_CR8
  publication-title: J Diabetes Metab
– volume: 27
  start-page: 1182
  year: 2004
  ident: BFijo201565_CR15
  publication-title: Diabetes Care
  doi: 10.2337/diacare.27.5.1182
– volume: 55
  start-page: 2277
  year: 2006
  ident: BFijo201565_CR35
  publication-title: Diabetes
  doi: 10.2337/db06-0062
– volume: 287
  start-page: R147
  year: 2004
  ident: BFijo201565_CR38
  publication-title: Am J Physiol Regul Integr Comp Physiol
  doi: 10.1152/ajpregu.00103.2004
– volume: 5
  start-page: 23
  year: 2002
  ident: BFijo201565_CR55
  publication-title: J Med Food
  doi: 10.1089/109662002753723197
– volume: 18
  start-page: 1695
  year: 2009
  ident: BFijo201565_CR12
  publication-title: Obesity (Silver Spring)
  doi: 10.1038/oby.2009.510
– volume: 32
  start-page: 2297
  year: 2009
  ident: BFijo201565_CR16
  publication-title: Diabetes Care
  doi: 10.2337/dc09-0574
– volume: 481
  start-page: 30
  year: 2009
  ident: BFijo201565_CR39
  publication-title: Arch Biochem Biophys
  doi: 10.1016/j.abb.2008.10.011
– volume: 5
  start-page: 660
  year: 2012
  ident: BFijo201565_CR25
  publication-title: Obes Facts
  doi: 10.1159/000343204
– volume: 282
  start-page: 1519
  year: 1999
  ident: BFijo201565_CR1
  publication-title: JAMA
  doi: 10.1001/jama.282.16.1519
– volume: 40
  start-page: D109
  year: 2011
  ident: BFijo201565_CR20
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/gkr988
– volume: 29
  start-page: 99
  year: 2007
  ident: BFijo201565_CR59
  publication-title: Physiol Genomics
  doi: 10.1152/physiolgenomics.00194.2006
– volume: 457
  start-page: 480
  year: 2009
  ident: BFijo201565_CR60
  publication-title: Nature
  doi: 10.1038/nature07540
– volume: 254
  start-page: 55
  year: 2003
  ident: BFijo201565_CR37
  publication-title: Mol Cell Biochem
  doi: 10.1023/A:1027332523114
– volume: 10
  start-page: 723
  year: 2014
  ident: BFijo201565_CR30
  publication-title: Nat Rev Endocrinol
  doi: 10.1038/nrendo.2014.171
– volume: 165
  start-page: 742
  year: 2005
  ident: BFijo201565_CR53
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.165.7.742
– volume: 122
  start-page: 1958
  year: 2012
  ident: BFijo201565_CR34
  publication-title: J Clin Invest
  doi: 10.1172/JCI63967
– volume: 135
  start-page: 1935
  year: 2008
  ident: BFijo201565_CR46
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2008.09.018
– volume: 10
  start-page: 109
  year: 2008
  ident: BFijo201565_CR57
  publication-title: Diabetes Obes Metab
  doi: 10.1111/j.1463-1326.2008.00866.x
– volume: 20
  start-page: 83
  year: 2007
  ident: BFijo201565_CR54
  publication-title: Am J Hypertens
  doi: 10.1016/j.amjhyper.2006.06.015
– volume: 9
  start-page: 4368
  year: 2010
  ident: BFijo201565_CR11
  publication-title: J Proteome Res
  doi: 10.1021/pr100101p
– volume: 119
  start-page: 1243
  year: 2012
  ident: BFijo201565_CR48
  publication-title: Obstet Gynecol
  doi: 10.1097/AOG.0b013e318255004e
– volume: 168
  start-page: 1617
  year: 2008
  ident: BFijo201565_CR3
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.168.15.1617
– volume: 33
  start-page: 13284
  year: 1994
  ident: BFijo201565_CR50
  publication-title: Biochemistry
  doi: 10.1021/bi00249a015
– volume: 48
  start-page: 905
  year: 2006
  ident: BFijo201565_CR43
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2006.09.004
– volume: 37
  start-page: 4553
  year: 1998
  ident: BFijo201565_CR49
  publication-title: Biochemistry
  doi: 10.1021/bi9722507
– volume: 93
  start-page: 4075
  year: 2008
  ident: BFijo201565_CR2
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2007-2724
– volume: 54
  start-page: 8
  year: 2005
  ident: BFijo201565_CR31
  publication-title: Diabetes
  doi: 10.2337/diabetes.54.1.8
– volume: 26
  start-page: 2342
  year: 2010
  ident: BFijo201565_CR21
  publication-title: Bioinformatics
  doi: 10.1093/bioinformatics/btq418
– volume: 320
  start-page: 345
  year: 1996
  ident: BFijo201565_CR22
  publication-title: Biochem J
  doi: 10.1042/bj3200345
– volume: 53
  start-page: 757
  year: 2010
  ident: BFijo201565_CR26
  publication-title: Diabetologia
  doi: 10.1007/s00125-009-1637-8
– volume: 86
  start-page: 1020
  year: 2001
  ident: BFijo201565_CR7
  publication-title: J Clin Endocrinol Metab
– volume: 4
  start-page: 214
  year: 2008
  ident: BFijo201565_CR27
  publication-title: Mol Syst Biol
  doi: 10.1038/msb.2008.50
– volume: 33
  start-page: 428
  year: 2011
  ident: BFijo201565_CR33
  publication-title: Brain Dev
  doi: 10.1016/j.braindev.2010.06.016
– volume: 398
  start-page: 107
  year: 2006
  ident: BFijo201565_CR32
  publication-title: Biochem J
  doi: 10.1042/BJ20060221
– volume: 86
  start-page: 1687
  year: 2007
  ident: BFijo201565_CR61
  publication-title: Am J Clin Nutr
  doi: 10.1093/ajcn/86.6.1687
– volume: 48
  start-page: 234
  year: 2013
  ident: BFijo201565_CR17
  publication-title: J Mass Spectrom
  doi: 10.1002/jms.3154
– volume: 63
  start-page: 2344
  year: 2014
  ident: BFijo201565_CR40
  publication-title: Diabetes
  doi: 10.2337/db13-0719
– volume: 4
  start-page: e201301009
  year: 2013
  ident: BFijo201565_CR18
  publication-title: Comput Struct Biotechnol J
  doi: 10.5936/csbj.201301009
– volume: 202
  start-page: 11
  year: 2009
  ident: BFijo201565_CR52
  publication-title: Atherosclerosis
  doi: 10.1016/j.atherosclerosis.2008.05.022
– volume: 36
  start-page: 2388
  year: 2013
  ident: BFijo201565_CR5
  publication-title: Diabetes Care
  doi: 10.2337/dc12-1971
– volume: 272
  start-page: C289
  year: 1997
  ident: BFijo201565_CR41
  publication-title: Am J Physiol
  doi: 10.1152/ajpcell.1997.272.1.C289
– volume: 5
  start-page: e10883
  year: 2010
  ident: BFijo201565_CR23
  publication-title: PLoS ONE
  doi: 10.1371/journal.pone.0010883
– volume: 124
  start-page: 1160
  year: 2011
  ident: BFijo201565_CR47
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.111.027375
– volume: 9
  start-page: 311
  year: 2009
  ident: BFijo201565_CR24
  publication-title: Cell Metab
  doi: 10.1016/j.cmet.2009.02.002
– volume: 879
  start-page: 2871
  year: 2011
  ident: BFijo201565_CR14
  publication-title: J Chromatogr B Analyt Technol Biomed Life Sci
  doi: 10.1016/j.jchromb.2011.08.014
– volume: 30
  start-page: 801
  year: 2010
  ident: BFijo201565_CR56
  publication-title: Nutr Res
  doi: 10.1016/j.nutres.2010.09.007
– volume: 1827
  start-page: 401
  year: 2013
  ident: BFijo201565_CR36
  publication-title: Biochim Biophys Acta
  doi: 10.1016/j.bbabio.2012.11.014
– volume: 34
  start-page: 1095
  year: 2010
  ident: BFijo201565_CR58
  publication-title: Int J Obes (Lond)
  doi: 10.1038/ijo.2010.44
– volume: 66
  start-page: 1890
  year: 2004
  ident: BFijo201565_CR42
  publication-title: Kidney Int
  doi: 10.1111/j.1523-1755.2004.00963.x
– volume: 24
  start-page: 242
  year: 2010
  ident: BFijo201565_CR10
  publication-title: Biomed Chromatogr
– volume: 90
  start-page: 4145
  year: 2005
  ident: BFijo201565_CR6
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2005-0482
– volume: 32
  start-page: 226
  year: 2000
  ident: BFijo201565_CR45
  publication-title: Dig Liver Dis
  doi: 10.1016/S1590-8658(00)80825-7
– volume: 35
  start-page: 839
  year: 2000
  ident: BFijo201565_CR51
  publication-title: Lipids
  doi: 10.1007/S11745-000-0593-z
– volume: 9
  start-page: 44
  year: 2012
  ident: BFijo201565_CR19
  publication-title: Metabolomics
  doi: 10.1007/s11306-012-0434-4
– volume: 19
  start-page: 883
  year: 2008
  ident: BFijo201565_CR44
  publication-title: Obes Surg
  doi: 10.1007/s11695-008-9521-z
– volume: 6
  start-page: 909
  year: 2010
  ident: BFijo201565_CR9
  publication-title: Mol BioSyst
  doi: 10.1039/b914182k
– volume: 97
  start-page: 2482
  year: 2012
  ident: BFijo201565_CR4
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2011-3475
– volume: 100
  start-page: 149
  year: 2015
  ident: BFijo201565_CR28
  publication-title: J Clin Endocrinol Metab
  doi: 10.1210/jc.2014-3157
– volume: 35
  start-page: 605
  year: 2012
  ident: BFijo201565_CR13
  publication-title: Diabetes Care
  doi: 10.2337/DC11-1577
– reference: 14674682 - Mol Cell Biochem. 2003 Dec;254(1-2):55-9
– reference: 16873691 - Diabetes. 2006 Aug;55(8):2277-85
– reference: 16686602 - Biochem J. 2006 Aug 15;398(1):107-12
– reference: 17941870 - Diabetes Obes Metab. 2008 Feb;10 (2):109-34
– reference: 22080510 - Nucleic Acids Res. 2012 Jan;40(Database issue):D109-14
– reference: 20634010 - Brain Dev. 2011 May;33(5):428-31
– reference: 17190852 - Physiol Genomics. 2007 Apr 24;29(2):99-108
– reference: 18065587 - Am J Clin Nutr. 2007 Dec;86(6):1687-93
– reference: 18695075 - Arch Intern Med. 2008 Aug 11;168(15):1617-24
– reference: 19356713 - Cell Metab. 2009 Apr;9(4):311-26
– reference: 19010326 - Gastroenterology. 2008 Dec;135(6):1935-44, 1944.e1
– reference: 15616005 - Diabetes. 2005 Jan;54(1):8-14
– reference: 17198917 - Am J Hypertens. 2007 Jan;20(1):83-9
– reference: 18682704 - Mol Syst Biol. 2008;4:214
– reference: 19606418 - Biomed Chromatogr. 2010 Mar;24(3):245-52
– reference: 24688690 - Comput Struct Biotechnol J. 2013 Mar 22;4:e201301009
– reference: 15111542 - Diabetes Care. 2004 May;27(5):1182-6
– reference: 9038835 - Am J Physiol. 1997 Jan;272(1 Pt 1):C289-94
– reference: 10984107 - Lipids. 2000 Aug;35(8):839-54
– reference: 20111019 - Obesity (Silver Spring). 2010 Sep;18(9):1695-700
– reference: 21147362 - Nutr Res. 2010 Dec;30(12 ):801-6
– reference: 22508708 - J Clin Endocrinol Metab. 2012 Jul;97(7):2482-8
– reference: 21423183 - Nat Med. 2011 Apr;17(4):448-53
– reference: 18952046 - Arch Biochem Biophys. 2009 Jan 1;481(1):30-6
– reference: 19729521 - Diabetes Care. 2009 Dec;32(12):2297-9
– reference: 23491523 - Diabetes Care. 2013 Aug;36(8):2388-94
– reference: 17162145 - Am J Kidney Dis. 2006 Dec;48(6):905-15
– reference: 23108202 - Obes Facts. 2012;5(5):660-70
– reference: 23220394 - Biochim Biophys Acta. 2013 Mar;1827(3):401-10
– reference: 7947736 - Biochemistry. 1994 Nov 15;33(45):13284-94
– reference: 20560578 - J Proteome Res. 2010 Sep 3;9(9):4368-75
– reference: 18585721 - Atherosclerosis. 2009 Jan;202(1):11-7
– reference: 25368978 - J Clin Endocrinol Metab. 2015 Jan;100(1):149-58
– reference: 10975773 - Dig Liver Dis. 2000 Apr;32(3):226-32
– reference: 23378096 - J Mass Spectrom. 2013 Feb;48(2):234-42
– reference: 11238480 - J Clin Endocrinol Metab. 2001 Mar;86(3):1020-5
– reference: 21844078 - Circulation. 2011 Sep 6;124(10 ):1160-71
– reference: 20628077 - Bioinformatics. 2010 Sep 15;26(18):2342-4
– reference: 15496160 - Kidney Int. 2004 Nov;66(5):1890-900
– reference: 15031134 - Am J Physiol Regul Integr Comp Physiol. 2004 Jul;287(1):R147-56
– reference: 19043404 - Nature. 2009 Jan 22;457(7228):480-4
– reference: 22833869 - J Clin Invest. 2012 Jun;122(6):1958-9
– reference: 21890434 - J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Oct 1;879(27):2871-6
– reference: 22266733 - Diabetes Care. 2012 Mar;35(3):605-11
– reference: 15855252 - J Clin Endocrinol Metab. 2005 Jul;90(7):4145-50
– reference: 20076942 - Diabetologia. 2010 Apr;53(4):757-67
– reference: 20526369 - PLoS One. 2010 May 28;5(5):e10883
– reference: 18431611 - Obes Surg. 2009 Jul;19(7):883-9
– reference: 10546690 - JAMA. 1999 Oct 27;282(16):1519-22
– reference: 25287287 - Nat Rev Endocrinol. 2014 Dec;10(12):723-36
– reference: 18682512 - J Clin Endocrinol Metab. 2008 Oct;93(10):4075-9
– reference: 20567778 - Mol Biosyst. 2010 May;6(5):909-21
– reference: 24550188 - Diabetes. 2014 Jul;63(7):2344-55
– reference: 8973539 - Biochem J. 1996 Dec 1;320 ( Pt 2):345-57
– reference: 15824292 - Arch Intern Med. 2005 Apr 11;165(7):742-8
– reference: 12511110 - J Med Food. 2002 Spring;5(1):23-36
– reference: 20212498 - Int J Obes (Lond). 2010 Jun;34(6):1095-8
– reference: 22617590 - Obstet Gynecol. 2012 Jun;119(6):1243-50
– reference: 9521776 - Biochemistry. 1998 Mar 31;37(13):4553-67
SSID ssj0005502
ssj0033214
Score 2.4997735
Snippet Objectives: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen...
Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen metabolomes of both...
OBJECTIVES: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen...
International Journal of Obesity (2015) 39, 1241-1248; doi:10.1038/ijo.2015.65
Objectives:Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen...
Objectives: Mechanisms of the development of abnormal metabolic phenotypes among obese population are not yet clear. In this study, we aimed to screen...
SourceID proquest
gale
pubmed
crossref
springer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1241
SubjectTerms 631/443/319/1642/393
631/443/319/320
692/308/174
Adult
Amine oxidase (flavin-containing)
Biosynthesis
Blood Glucose - metabolism
Body Fat Distribution
Body Mass Index
Body size
Body weight loss
Chromatography
Clinical outcomes
Diabetes
Discriminant analysis
Dyslipidemia
Epidemiology
Fatty acids
Female
Gas chromatography
Glycerol
Glycolic acid
Health care
Health Promotion and Disease Prevention
Hospitals
Humans
Hyperglycemia
Hypertension
Indexing
Inflammation - metabolism
Inflammation - physiopathology
Internal Medicine
Isoleucine
Leucine
Liquid chromatography
Male
Mass spectrometry
Mass spectroscopy
Medical research
Medicine
Medicine & Public Health
Medicine, Experimental
Metabolic Diseases
Metabolic disorders
Metabolic Networks and Pathways
Metabolic pathways
Metabolism
Metabolites
Metabolome
Metabolomics
Metabolomics - methods
Obesity
Obesity - metabolism
Obesity - physiopathology
original-article
Palmitic acid
Phenotypes
Phenylalanine
Preventive medicine
Public Health
Regression analysis
Risk Factors
Scientific imaging
Spectroscopy
Taiwan
Topology
Uric acid
Valine
Title The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity
URI https://link.springer.com/article/10.1038/ijo.2015.65
https://www.ncbi.nlm.nih.gov/pubmed/25907313
https://www.proquest.com/docview/1701284254
https://www.proquest.com/docview/2331625726
https://www.proquest.com/docview/1702089167
https://www.proquest.com/docview/1732826403
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR39a9Qw9KEbiCCi51d1zghTQahrmzRNf5I5N4bgIeLwfitJm8LJrZ1eh-y_970m7d3NsV_KQV5zad7L-8j7Atircl6r1JLTnZtQSKVDk1VVKHglIhNlJT4o2mIqT07Fl1k68xduSx9WOfDEnlFXbUl35PtUNzwhn5H4eP47pK5R5F31LTRuwzaVLiPjK5tlqxCPNBprSXHqyDNURUSpn_pkvYir_fkvSgOM0w8kYtbE01UmvSalrrhNe2l0_ADuezWSHTi8P4RbtplA8HluO_aW-VqfCzYdSu1P4M5X70SfwD13VcdcBtIEJivVEV_u254vH8FPJCB2ZjskkkV7Zplr7o2LYbqpGDUy_qsv8beracLmzQCMM7vkysseUpuG1OIFa10Lgsdwenz04_Ak9F0YwjLN8i60Nk9QAxcRt7KWKuOxRVSkZYrSNeK1zlXNuZQmjxNtSqWEthJ5Zp0L1EV1LvgT2Graxj4DZhSZ4lKbXCtR5akm9dRmcWJ4JaPSBPB-2Pyi9CXKqVPGouhd5VwViKmCMFXINIC9EfjcVea4HuwVYbFwXz6e5-IASUkh0SRZAO96CDrR-G-l9okJuGaqjbUBubMBiSex3BweKKXwnGBZrOj22uGE8xhN0CyRAbweh2liCn5rbHvRT5FECvX47CYYjsazRCwF8NQR6bgraOEiI49x5M1AtWvr-3_Lnt_8HS_gLgG6KMgd2Or-XNiXqJl1Zrc_fvhUh_EubH86mn77_g8P3zRc
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1dT9RAcIKYKIkxen5VUdYENDGptN3tdvtgDAHJIXBPEHkru-1ecuTooVdC7k_5G53ptuUOCW-8NE12ut3uzM5H5wtgvUj5UMWWnO7c-EIq7ZukKHzBCxGYIMnxQtEWA9k_Fj9P4pMl-NvmwlBYZcsTa0ZdTHL6R75JdcMj8hmJ7xe_feoaRd7VtoWGI4t9O7tCk236bW8H8bsRRbs_jrb7ftNVwM_jJK18a9MINUoRcCuHUiU8tDh1nMcoLQI-1Kkaci6lScNIm1wpoa1EHjBMBepWOhUc530ADwXnCdXqV9tzISVx0NWu4tQBqK3CiFpG3CQHBlxtjs4o7TCMv5JImxOHN4XCnFS84aatpd_uM3jaqK1sy9HZc1iyZQ-8nZGt2CfW1BYds0Fb2r8Hjw4bp30Pnrhfg8xlPPWgd62q4sN1m_XpC_iFBMvObYVEOZ6cW-aaieNimC4LRo2Tr_QM710NFTYqW2Cc2SVzzmpIbUpSw8ds4loevITje8HPK1guJ6V9A8woMv2lNqlWokhjTeqwTcLI8EIGufHgS7v5Wd6URKfOHOOsds1zlSGmMsJUJmMP1jvgC1cJ5HawNcJi5r684x_ZFpKuClGfTjz4XEMQB8G35bpJhMA1Uy2uBcjVBUg8-fnicEspWcN5ptn1Obl1OOI8RJM3iaQHH7thmpiC7Uo7uayniAKFdkNyFwxHY10iljx47Yi02xW0qFFwhDiy0VLt3Pr-37K3d3_HGjzuHx0eZAd7g_13sEIPuQjMVViu_lza96gVVuZDfRQZnN732f8Hfa5uSg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw8DSGNCEhBOUrYzAjbSAhhSZxYjsPCE2UamNQ8cBE34KdOFJRl26009S_xq_jLk76Maa97aWq5Ivj-M734fsC2CtSXqrEktOdGz8WSvtGFoUf8yIOTCBz_KFoi4E4PIm_DJPhBvxtc2EorLLliTWjLiY53ZF3qW54RD6juFs2YRHfe_2PZ-c-dZAiT2vbTsORyLGdX6L5Nv1w1ENc70dR__OPT4d-02HAzxOZznxr0wi1yzjgVpRCSR5afE2SJyg5Al7qVJWcC2HSMNImVyrWViA_KNMY9SydxhznvQN3JUexiWdJDuUyvCQJFnWsOHUDaisyosaRNImCAVfd0W9KQQyT9yTeVkTjVQGxIiGvuGxrSdh_CA8aFZYdOJp7BBu26oDXG9kZe8OaOqNjNmjL_Hdg61vjwO_AfXdNyFz2Uwc6S7UVH65brk8fw08kXnZqZ0ig48mpZa6xOC6G6apg1ET5Us_xv6unwkZVC4wzu8TOeQ2pTUUq-ZhNXPuDJ3ByK_h5CpvVpLLPgRlF1wBCm1SruEgTTaqxlWFkeCGC3Hjwrt38LG_Ko1OXjnFWu-m5yhBTGWEqE4kHewvgM1cV5HqwXcJi5r58wUuyAyRjFaJuLT14W0MQN8G35bpJisA1U12uNcidNUjkAvn6cEspWcOFptnyzFw7HHEeovkrI-HB68UwTUyBd5WdXNRTRIFCG0LeBMPRcBeIJQ-eOSJd7Apa1yhEQhzZb6l2ZX3_b9n2zd-xC1t46rOvR4PjF3CPnnHBmDuwOftzYV-igjgzr-qTyODXbR_9f0SKcqw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+metabolome+profiling+and+pathway+analysis+in+metabolic+healthy+and+abnormal+obesity&rft.jtitle=International+Journal+of+Obesity&rft.au=Chen%2C+H-H&rft.au=Tseng%2C+Y+J&rft.au=Wang%2C+S-Y&rft.au=Tsai%2C+Y-S&rft.date=2015-08-01&rft.pub=Nature+Publishing+Group+UK&rft.issn=0307-0565&rft.eissn=1476-5497&rft.volume=39&rft.issue=8&rft.spage=1241&rft.epage=1248&rft_id=info:doi/10.1038%2Fijo.2015.65&rft.externalDocID=10_1038_ijo_2015_65
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0307-0565&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0307-0565&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0307-0565&client=summon